Showing 8,741 - 8,760 results of 103,707 for search '(( e non decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 8741
  2. 8742
  3. 8743
  4. 8744
  5. 8745
  6. 8746
  7. 8747
  8. 8748
  9. 8749
  10. 8750
  11. 8751
  12. 8752
  13. 8753
  14. 8754
  15. 8755
  16. 8756

    T0 treatment significantly decreased soluble Aβ oligomers, but not amyloid plaque pathology in APP/E4/Abca1<sup>+/-</sup> mice. by Alexis Y. Carter (3798223)

    Published 2017
    “…N = 5–6 mice per group. N.S., not significant. <b>E,</b> T0 treatment significantly decreases Aβ oligomers in APP/E4/Abca1<sup>+/-</sup> mice. …”
  17. 8757
  18. 8758
  19. 8759

    Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner by Khondoker Alam (1443499)

    Published 2017
    “…Compared with vehicle control treatment, bortezomib pretreatment significantly decreased the maximal transport velocity (V<sub>max</sub>) of OATP1B3-mediated transport of CCK-8 (92.25 ± 14.2 vs. 133.95 ± 15.5 pmol/mg protein/min) without affecting the affinity constant (K<sub>m</sub>) values. …”
  20. 8760

    Expression of 5-HT<sub>4(b)</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HTT mRNA in left ventricular myocardium. by Trond Brattelid (290970)

    Published 2013
    “…(A) 5-HT<sub>4(b)</sub> mRNA levels decreased with foetal and neonatal development and the level in adult myocardium was one tenth of that at day -3 but reappeared in HF; (B) 5-HT<sub>2A</sub> mRNA expression increased at birth (day 1), decreased during neonatal development and was unaltered in HF; (C) 5-HT<sub>2B</sub> mRNA expression was transiently increased at birth (day 1) compared to adult (day 113) and not changed in HF; (D) 5-HTT mRNA expression was lower in foetal hearts compared to neonatal, adult, Sham and HF which all showed a similar expression level. …”